Lapatinib

Lapatinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T0078-10mg 10 mg

7 - 10 business days*

30.00€
TGM-T0078-1mL 1 ml

7 - 10 business days*

31.00€
TGM-T0078-25mg 25 mg

7 - 10 business days*

38.00€
TGM-T0078-50mg 50 mg

7 - 10 business days*

49.00€
TGM-T0078-100mg 100 mg

7 - 10 business days*

67.00€
TGM-T0078-200mg 200 mg

7 - 10 business days*

83.00€
TGM-T0078-500mg 500 mg

7 - 10 business days*

128.00€
 
Description: Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral... more
Product information "Lapatinib"
Description: Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity. Lapatinib has antitumor activity and can be used to treat advanced or metastatic breast cancer with HER2 overexpression. Target: Autophagy, EGFR, Ferroptosis. Smiles: N(C=1C2=C(C=CC(=C2)C=3OC(CNCCS(C)(=O)=O)=CC3)N=CN1)C4=CC(Cl)=C(OCC5=CC(F)=CC=C5)C=C4. References: Wainberg ZA, et al. Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo. Clin Cancer Res. 2010 Mar 1,16(5):1509-19.
Keywords: GW572016, GSK572016
Supplier: TargetMol
Supplier-Nr: T0078

Properties

MW: 581.06 D
Formula: C29H26ClFN4O4S

Database Information

CAS : 231277-92-2| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H319, H362, H413
P Phrases: P201, P260, P263, P264, P270, P273, P280, P305+351+338, P308+313, P337+313, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Lapatinib"
Write a review
or to review a product.
Viewed